Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04001725
What this trial is testing

Efficacy of metfOrmin in PrevenTIng Glucocorticoid-induced Diabetes in Patients With Brain Metastases

Who this might be right for
Brain MetastasesMelanomaLung Cancer+1 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 110
Testing effectiveness (Phase 2)UnknownNCT03366376
What this trial is testing

Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC

Who this might be right for
Brain Metastases
Samsung Medical Center 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05660408
What this trial is testing

RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors

Who this might be right for
Recurrent Pulmonary OsteosarcomaRecurrent High-grade Glioma
University of Florida 36
Large-scale testing (Phase 3)Active Not RecruitingNCT04093167
What this trial is testing

Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer

Who this might be right for
Lung Cancer
Canadian Cancer Trials Group 53
Not applicableStudy completedNCT00409136
What this trial is testing

Multi-Center Human Alert Trial to Prevent DVT and PE

Who this might be right for
Pulmonary EmbolismDeep Vein ThrombosisCancer+1 more
Brigham and Women's Hospital 2,496
Testing effectiveness (Phase 2)UnknownNCT06403111
What this trial is testing

FMT+Immunotherapy+Chemotherapy As First-line Treatment for Driver-gene Negative Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Changzhou No.2 People's Hospital 62
Large-scale testing (Phase 3)Active Not RecruitingNCT05984277
What this trial is testing

A Global Study of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for Participants With Metastatic Non-small Cell Lung Cancer.

Who this might be right for
Metastatic Non-small Cell Lung Cancer
AstraZeneca 895
Not applicableActive Not RecruitingNCT06055972
What this trial is testing

Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health

Who this might be right for
Coronary Artery DiseaseCardiovascular DiseasesSmoking
American College of Radiology 800
Testing effectiveness (Phase 2)Active Not RecruitingNCT05801029
What this trial is testing

Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
AstraZeneca 60
Testing effectiveness (Phase 2)Ended earlyNCT03207867
What this trial is testing

NIR178 in Combination With PDR001 in Patients With Solid Tumors and Non-Hodgkin Lymphoma

Who this might be right for
NSCLC, Non Small Cell Lung CancerRCC, Renal Cell CancerPancreatic Cancer+7 more
Novartis Pharmaceuticals 315
Testing effectiveness (Phase 2)WithdrawnNCT00090701
What this trial is testing

A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Lung Neoplasms
Pfizer
Testing effectiveness (Phase 2)Looking for participantsNCT06695845
What this trial is testing

Zanidatamab in Patients With HER2-expressing Tumors

Who this might be right for
Breast CancerGastric CancerEsophageal Cancer+9 more
Jazz Pharmaceuticals 200
Testing effectiveness (Phase 2)WithdrawnNCT02425072
What this trial is testing

NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer

Who this might be right for
Small Cell Lung CancerBrain Metastasis
John Villano
Not applicableStudy completedNCT03521375
What this trial is testing

VIdeo Assisted Thoracoscopic Lobectomy Versus Conventional Open LobEcTomy for Lung Cancer

Who this might be right for
Lung Neoplasms
University of Bristol 503
Not applicableEnded earlyNCT01409681
What this trial is testing

A Multi-Centered Trial Evaluating the Role of Vitamin D Metabolism in Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
University of Michigan Rogel Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT01844765
What this trial is testing

Open Label, Phase II Study to Evaluate Efficacy and Safety of Oral Nilotinib in Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML) Pediatric Patients.

Who this might be right for
Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 59
Not applicableLooking for participantsNCT06147414
What this trial is testing

Development of Non-Invasive Prenatal Diagnosis for Single Gene Disorders

Who this might be right for
Invasive PreNatal Diagnosis in a Context of Family History of Single-gene Disorders, IncludingSickle Cell DiseaseCystic Fibrosis+12 more
Assistance Publique - Hôpitaux de Paris 550
Not applicableNot Yet RecruitingNCT07185958
What this trial is testing

Dual Energy CT - a Tool for Delineation of Tumor and Organs at Risk in Radiotherapy

Who this might be right for
Brain MetastasesBone MetastasesHead and Neck Cancer+1 more
Aalborg University Hospital 80
Early research (Phase 1)Ended earlyNCT04025216
What this trial is testing

CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerOvarian CancerFallopian Tube Cancer+3 more
Kite, A Gilead Company 16
Not applicableStudy completedNCT05043155
What this trial is testing

Strategies to Continue Gynae-oncology Services in the Era of COVID-19 Outbreak: Concerns and Challenges in a Referral Centre in Malaysia

Who this might be right for
Covid19Vaccination RefusalSurvivorship
Universiti Kebangsaan Malaysia Medical Centre 100
Next Page